ClinicalTrials.Veeva

Menu

Models of Care in the Transition From the Secondary to the Primary Sector Among the Frailest Elderly

University of Aarhus logo

University of Aarhus

Status

Completed

Conditions

Aging
Elderly
Readmission
Transitional Care
Frailty
Frail Elderly Syndrome

Treatments

Other: Early follow-up visit after discharge
Other: Continued geriatric care
Other: Possible follow-up visit from GP
Other: Comprehensive geriatric assessment (CGA)

Study type

Interventional

Funder types

Other

Identifiers

NCT03796923
MOCATRANFRAELRCT

Details and patient eligibility

About

In most Western countries the elderly population increases rapidly. In Denmark, the population of elderly aged 75 years or older may amount to nearly 15 % of the entire population in 2050 compared to 9 % today (2017). A large part of the elderly population is at high risk of hospitalization including more admissions and increased morbidity and mortality. The number of hospital beds is declining persistently, calling for shorter lengths of stay (LOS). Increasingly complex treatments now take place outside hospital. Presently, many Danish regional hospitals establish geriatric wards and other geriatric in-hospital and outpatient services to overcome these challenges. The aim of the present PhD-study is to investigate the effects of different models of transitional care among the frailest elderly patients.

Full description

Design Population: The frailest acutely admitted geriatric patients aged +75. Intervention: Early follow-up visits after discharge. Comparison: Usual care follow-up. Outcomes: The primary outcome is readmission within 30 days after discharge. Secondary outcomes are: mortality 30 days after discharge and 90 days after admission, length of stay (LOS), direct discharge from the Emergency Department, time at home before readmission, duration of readmission and physical functional status 30 days after discharge.

Methods The first study is conducted as a randomized controlled trial (RCT) using two different degrees of intervention. The second study is a cohort study of an unexposed control group. The third study is sub-group analyses of the RCT data according to frailty status and type of dwelling.

A focus group comprised of included patients and relatives will be set to identify additional patient related outcome measures (PROMs) and to participate in an advisory group throughout the remaining project.

Enrollment

3,340 patients

Sex

All

Ages

75+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Aged 75 years or older
  • Living within the municipality of Aarhus (except for the control group, see below)
  • MPI-score = 2 (moderate frailty) or MPI score = 3 (severe frailty)

Exclusion Criteria

  • Included in any other kind of follow-up schemes
  • Declared terminally ill or undergoing palliative care at admission
  • Admitted from one specific temporary nursing home with geriatric medical assistance
  • Discharge or transfer to another department, including hospice
  • MPI-score = 1 (low frailty)
  • Discharged to one specific temporary nursing home with geriatric medical assistance
  • The patient does not want a visit after discharge

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

3,340 participants in 3 patient groups

Intervention I
Active Comparator group
Description:
Intervention (I): early follow-up visit from the community nurse within 24 hours after discharge
Treatment:
Other: Early follow-up visit after discharge
Other: Comprehensive geriatric assessment (CGA)
Intervention II
Experimental group
Description:
Intervention (II): early follow-up by the geriatric team within 24 hours after discharge
Treatment:
Other: Early follow-up visit after discharge
Other: Continued geriatric care
Other: Comprehensive geriatric assessment (CGA)
Control
Other group
Description:
Usual care: individualized follow-up performed by the GP and municipality services
Treatment:
Other: Possible follow-up visit from GP

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems